Current filters:  
Canada
Healthcare
Canada
Fasken
On January 26, Health Canada issued a notice clarifying how a drug's "dormant" status on the drug product database may affect whether that drug...
Fasken
The federal Parliament tabled Bill C-64, An Act respecting pharmacare (the "Bill"), on February 29, 2024. The Bill outlines the first phase of the federal government's...
Fasken (French)
Le 26 janvier, Santé Canada a publié un avis précisant comment l'état « dormant » d'un médicament dans la base de données sur les produits pharmaceutiques...
Miller Thomson LLP
On February 13, 2024, Ontario's Divisional Court released its decision in Spirou v. College of Physiotherapists of Ontario ("Spirou"), with the Court confirming that the College...
McCarthy Tétrault LLP
Earlier this month, the NDP and the Liberals announced a deal to introduce the first piece of a national pharmacare program providing federal funding for medications for Canadians.
Gardiner Roberts LLP
An investigative report published yesterday on CBC.ca reveals that former Shoppers Drug Mart (SDM) employees are alleging that intense pressure from SDM...
Torys LLP
Agriculture has historically been among Canada's most important economic drivers. However, it is marked by unique challenges including changing environmental conditions...
Gardiner Roberts LLP
As legal counsel for chiropractors, we are often asked questions about what happens when a chiropractor is referred to the Discipline Committee of the College of Chiropractors of Ontario (the "CCO").
Smart & Biggar
We previously reported Health Canada's March 27, 2023 consultation on its proposed application of the definition of Canadian reference product (CRP) based on "Dormant Status" under s. C.08.001.1(b)...
Gowling WLG
On May 12, 2023, Health Canada published a cost recovery proposal for natural health products (NHPs). The dietary supplement industry's response has been overwhelmingly critical of the proposal for a variety of reasons.
Smart & Biggar
On May 26, 2023, the Minister of Health determined that Biosimilar Collaborations Ireland Limited was entitled to the benefit of section 5 of the Patented Medicines (Notice of Compliance) Regulations (Regulations)...
Gardiner Roberts LLP
In my opinion, here are the top 10 items that Health Professionals need to know about Discipline Committee hearings...
Cassels
The Patented Medicine Prices Review Board Canada (PMPRB) published its "What We Learned Report" (Report) on February 15, 2024...
Fillmore Riley
Made in Canada and Product of Canada claims can set your product apart. Knowing the rules around their use and how to obtain them could provide the marketing and advertising edge your business needs.
Smart & Biggar
We previously reported amendments to Part 1.1 of the Medical Devices Regulations that created a permanent regulatory framework for expediting access to COVID-19 medical devices.
Smart & Biggar
On December 23, 2023, the Federal Court of Appeal (FCA) held that it was an abuse of process for Apotex to raise invalidity in defending actions under the Patented Medicines...
Fasken
On January 3, 2024, the Regulations Amending the Medical Devices Regulations (Medical Devices for an Urgent Public Health Need) (the "Amended Regulations") came into force.
Bennett Jones LLP
Yu v 16 Pet Food & Supplies Inc., 2023 BCCA 397 (16 Pet Food), establishes a new test for pre-trial injunctions against defamatory speech in British Columbia.
Osler, Hoskin & Harcourt LLP
On January 18, 2024, Canada, Nunavut and Nunavut Tunngavik Inc. (NTI) (collectively, the parties) signed the Nunavut Lands and Resources Devolution Agreement (the Agreement).
Fasken
On January 5, 2024, the U.S. Food and Drug Administration (FDA) signed off on Florida's request to import prescription drugs from Canada under the Section 804 State Importation Program (SIP).
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media